Social Networking of Group Two Innate Lymphoid Cells in Allergy and Asthma
Allergic diseases including asthma, chronic rhinosinusitis, and atopic dermatitis are common conditions worldwide. While type 2 immune responses induced by T-cells significantly cause allergic inflammation, the recently identified group two innate lymphoid cells (ILC2s) are emerging as critical play...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2018-11-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2018.02694/full |
| _version_ | 1818772389124636672 |
|---|---|
| author | Benjamin P. Hurrell Pedram Shafiei Jahani Omid Akbari |
| author_facet | Benjamin P. Hurrell Pedram Shafiei Jahani Omid Akbari |
| author_sort | Benjamin P. Hurrell |
| collection | DOAJ |
| description | Allergic diseases including asthma, chronic rhinosinusitis, and atopic dermatitis are common conditions worldwide. While type 2 immune responses induced by T-cells significantly cause allergic inflammation, the recently identified group two innate lymphoid cells (ILC2s) are emerging as critical players in the development of allergy. Upon allergen exposure, ILC2s are rapidly activated by cytokines released by epithelial cells. Activated ILC2s release various effector cytokines altogether contributing to the pathogenesis of allergy and can even cause inflammation in the absence of T-cells, as observed in asthma. Although the factors inducing ILC2 activation have been identified, evidence suggests that multiple factors can enhance or repress ILC2 proliferation, trafficking, or secretion of effector cytokines upon allergic inflammation. In this review, we discuss the recent findings that influence ILC2 activation and the resulting effects on the pathogenesis of allergy. A better understanding of how ILC2s are modulated will open the door to the development of new therapeutic strategies against allergic diseases. |
| first_indexed | 2024-12-18T10:08:34Z |
| format | Article |
| id | doaj.art-6574d13523e743daad4a09bae0fc2085 |
| institution | Directory Open Access Journal |
| issn | 1664-3224 |
| language | English |
| last_indexed | 2024-12-18T10:08:34Z |
| publishDate | 2018-11-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Immunology |
| spelling | doaj.art-6574d13523e743daad4a09bae0fc20852022-12-21T21:11:30ZengFrontiers Media S.A.Frontiers in Immunology1664-32242018-11-01910.3389/fimmu.2018.02694426331Social Networking of Group Two Innate Lymphoid Cells in Allergy and AsthmaBenjamin P. HurrellPedram Shafiei JahaniOmid AkbariAllergic diseases including asthma, chronic rhinosinusitis, and atopic dermatitis are common conditions worldwide. While type 2 immune responses induced by T-cells significantly cause allergic inflammation, the recently identified group two innate lymphoid cells (ILC2s) are emerging as critical players in the development of allergy. Upon allergen exposure, ILC2s are rapidly activated by cytokines released by epithelial cells. Activated ILC2s release various effector cytokines altogether contributing to the pathogenesis of allergy and can even cause inflammation in the absence of T-cells, as observed in asthma. Although the factors inducing ILC2 activation have been identified, evidence suggests that multiple factors can enhance or repress ILC2 proliferation, trafficking, or secretion of effector cytokines upon allergic inflammation. In this review, we discuss the recent findings that influence ILC2 activation and the resulting effects on the pathogenesis of allergy. A better understanding of how ILC2s are modulated will open the door to the development of new therapeutic strategies against allergic diseases.https://www.frontiersin.org/article/10.3389/fimmu.2018.02694/fullILC2allergic diseaseasthmaactivationinhibition |
| spellingShingle | Benjamin P. Hurrell Pedram Shafiei Jahani Omid Akbari Social Networking of Group Two Innate Lymphoid Cells in Allergy and Asthma Frontiers in Immunology ILC2 allergic disease asthma activation inhibition |
| title | Social Networking of Group Two Innate Lymphoid Cells in Allergy and Asthma |
| title_full | Social Networking of Group Two Innate Lymphoid Cells in Allergy and Asthma |
| title_fullStr | Social Networking of Group Two Innate Lymphoid Cells in Allergy and Asthma |
| title_full_unstemmed | Social Networking of Group Two Innate Lymphoid Cells in Allergy and Asthma |
| title_short | Social Networking of Group Two Innate Lymphoid Cells in Allergy and Asthma |
| title_sort | social networking of group two innate lymphoid cells in allergy and asthma |
| topic | ILC2 allergic disease asthma activation inhibition |
| url | https://www.frontiersin.org/article/10.3389/fimmu.2018.02694/full |
| work_keys_str_mv | AT benjaminphurrell socialnetworkingofgrouptwoinnatelymphoidcellsinallergyandasthma AT pedramshafieijahani socialnetworkingofgrouptwoinnatelymphoidcellsinallergyandasthma AT omidakbari socialnetworkingofgrouptwoinnatelymphoidcellsinallergyandasthma |